生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | The glucose transporter GLUT1 is overexpressed in various types of human cancers. BAY-876 is a highly selective GLUT1 inhibitor with an IC50 value of 2 nM. The IC50 values of BAY-876 for GLUT2, 3, and 4 are 10.8, 1.67, and 0.29 µM[2]. The treatment with BAY-876 (25 – 75 nM) decreased glycolytic rates in SKOV-3, OVCAR-3, and HEY cells in a dose-dependent manner. BAY-876 at doses of 75 nM reduced basal and CoCl2-stimulated glycolysis in SKOV-3, OVCAR-3, and HEY cells. Incubation of SKOV-3 and OVCAR-3 cells with 75 nM BAY-876 caused a significant decrease in cellular ATP level. BAY-876 also inhibited the mitochondrial activity of viable cells with IC50 values of 60, 188, and 1002 nM for OVCAR-3, SKOV-3, and HEY cells, respectively. In female NSG mice carrying SKOV-3 xenografts, the administration of BAY-876 (1.5 - 4.5 mg/kg/day) for 4 weeks does-dependently inhibited tumor growth as compared to the group received no BAY-876 treatment[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.01mL 0.40mL 0.20mL |
10.07mL 2.01mL 1.01mL |
20.14mL 4.03mL 2.01mL |
参考文献 |
---|